This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Halftime for Heidelberg
Spar, Debora L.Case HBS-720021-EStrategyThe case follows President Rob Huntington as he seeks to find a viable way forward for Heidelberg University. Located in Tiffin, Ohio, Heidelberg is a small, private, four-year university. As with many similar institutions of higher education, it currently faces a daunting and mounting set of challenges, most of which stem from financial and demographic changes that are far beyond its control. During Huntington's eleven-year tenure, the universi...Starting at €8.20
-
Afrigen Biologics: Vaccines for the Global South, Teaching Note
Spar, Debora L.; Comeau, JuliaTeaching Note HBS-323098-EEconomicsTeaching note to case 323030Starting at €0.00
-
The Social Purpose of the Firm
Spar, Debora L.; Comeau, JuliaCase HBS-323051-EKnowledge and CommunicationThe Social Purpose of the Firm (SPF) is a short module designed to explore how, and under what circumstances, business leaders can harness the power of capitalism and markets to "make a difference in the world" - that is, to address a significant societal problem as a commercial endeavor. This Module Note summarizes the cases and themes discussed in SPF. Together, the cases are designed to study entrepreneurs and business leaders who are tackling...Starting at €8.20
-
Extend Fertility: Conceiving the Market for Egg Preservation, Teaching Note
Spar, Debora L.; Hull, OliviaTeaching Note HBS-720002-EStrategyTeaching note for case 719019.Starting at €0.00
-
Afrigen Biologics: Vaccines for the Global South
Spar, Debora L.; Comeau, JuliaCase HBS-323030-EEconomicsThe majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO) is seeking to lessen this disparity by putting vaccine production in the hands of South Africans and other low- and middle-income countries. Afrigen Biologics is the first in a plann...Starting at €8.20
-
-
-
Executing Active Investment Strategies
Hanson, Samuel G.Case HBS-219080-EFinanceStarting at €8.20
-
Merger Arbitrage at Tannenberg Capital
Hanson, Samuel G.Case HBS-218065-EFinanceStarting at €8.20
-
Estimating the Equity Risk Premium
Hanson, Samuel G.; Greenwood, Robin; Biery, DavidCase HBS-216074-EFinanceStarting at €8.20